Position in AGIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$91,882,280
+$9,242,360 QoQ
Shares Held
2,716,000
-10.5% QoQ
Ownership
4.57%
of shares outstanding
% of Portfolio
3.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Derivatives in AGIO
reported options exposure · as of Mar 31, 2026CallValue
$108,256,000
CallShares
3,200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARMISTICE CAPITAL, LLC holds $1,388,824,976 across 55 Biotechnology names. AGIO ranks #4 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
4,897,417 | $145,502,259 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
2,074,449 | $141,332,210 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
264,583 | $138,501,263 | |
| 4 | AGIO |
Agios Pharmaceuticals, Inc.
This page
|
2,716,000 | $91,882,280 | |
| 5 | IMVT |
Immunovant, Inc.
|
3,564,916 | $88,552,513 | |
| 6 | INCY |
Incyte Corp
|
656,817 | $61,819,616 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,175,110 | $57,564,744 | |
| 8 | CYTK |
Cytokinetics Inc
|
764,538 | $50,390,699 |
All Filings in AGIO
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $91,882,280 | 2,716,000 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $108,256,000 | 3,200,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $81,660,000 | 3,000,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $82,639,920 | 3,036,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $36,126,000 | 900,000 | Call | Sole | 2025-11-17 | |
| 2025-09-30 | $30,666,960 | 764,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $38,847,680 | 1,168,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $60,006,400 | 2,048,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $74,405,029 | 2,264,304 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $98,060,120 | 2,207,070 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $89,652,991 | 2,079,151 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $86,667,360 | 2,964,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $78,479,480 | 3,524,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $82,269,000 | 3,324,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $92,209,920 | 3,256,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $79,476,200 | 3,460,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $77,220,000 | 2,750,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $54,410,720 | 1,924,000 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||